期刊文献+

丹参对原发性高血压患者hs-CRP、sICAM-1及内皮功能的影响 被引量:11

The effect of salvia miltiorrhiza on the hs-CRP,sICAM-1 and the vascular eadothellum in essential hypertension patients
在线阅读 下载PDF
导出
摘要 目的探讨丹参对原发性高血压患者炎症因子hs-CRP、sICAM-1及血管内皮功能的影响。方法 82例原发性高血压病患者,随机分为对照组(41例)和丹参组(41例),治疗14d后,采用放免法测定CGRP,6-Keto-PGF1α,ET-1,TXB2;ELISA法检测血清sICAM-1;激光散射比浊法测定hs-CRP。结果丹参组治疗后炎症因子hs-CRP、sICAM-1下降明显;血浆ET-1、TXB2下降,CGRP,6-Keto-PGF1α上升显著,与对照组比较,差异具有显著性(P<0.01orP<0.05)。结论丹参能够明显减轻原发性高血压患者炎症反应,抑制ET、TXA2和提高血管内皮CGRP、PGI2的作用,其保护血管内皮功能疗效显著。 Objective To explore the effect of salvia miltiorrhiza on the inflammatory mediators hs- CRP, sICAM-1 and the vascular endothelia in essential hypertension patients. Methods 82 essential hyperten- sion patients were randomly divided into control group( n =41 ) , salvia miltiorrhiza group( n =41 ) , The levels of CGRP, 6-Keto-PGFlct, ET-1, TXB2 were determined by the method of radioimmiunity, the serum level of sICAM-1 were detected by ELISA while the level of hs-CRP were detected by the method of laser nephelometry after two weeks treatment. Results After treatment, in salvia miltiorrhiza group, the inflammatory mediators hs-CRP, sICAM-1 were significantly decreased, The levels of plasma ET-1, TXB2 were significantly decreased and the levels of plasma CGRP, 6-Keto-PGFlct were significantly increased much more than those in the control group( P 〈 0.01 or P 〈 0. 05 ). Conclusion Salvia mihiorrhiza has inhibition effect the inflammatory react on the essential hypertension patients, and can inhibvition effect on ET, TXA2 bet elevates CGRP, PGI2, it effect on protection of vascular endothelia of essential hypertension patients is significant.
作者 张淑涛
出处 《中国实用医药》 2010年第17期3-5,共3页 China Practical Medicine
关键词 原发性高血压 炎症因子 血管内皮功能 丹参 Essential hypertension Inflammatory mediators Vascular endothelial function Salvia miltiorrhiza
  • 相关文献

参考文献13

  • 1Schutta MH.Diabetes and hypertension:epidemiology of the relationship and pathophyaiology of factors associated with these comorbid conditions.ardiometab Syndr,2007,2:124-130.
  • 2Li J,Wang DH.Development of angiotensin II-induced hypertension:role of CGRP and its recepter.J Hypertens,2005,23:113-118.
  • 3Clearfield MB.C-reactive protein:a new risk assessment tool for cardiovascular disease.J Am Osteepath Assoc,2005,195(9):409-416.
  • 4谢文艳,陈金水,吴天敏,林圣远,许昌声,王华军.复方丹参滴丸对自发性高血压大鼠血管重构的影响[J].中西医结合心脑血管病杂志,2009,7(5):549-550. 被引量:3
  • 5段留法,郑秋甫,张丽萍,曾强,范英鲜,唐朝枢.自发性高血压大鼠血管内皮功能不全发生机理实验研究[J].中国康复理论与实践,2005,11(6):413-414. 被引量:7
  • 6李建军.高血压可能是一种炎症相关性疾病[J].高血压杂志,2005,13(9):526-527. 被引量:46
  • 7Boulanger CM.Secondary endothelial dysfunction:hypertension and heart failure.J Mol Cell Cardiol,1999,31:39-49.
  • 8Cheng Y,Austin SC,ROcca B.et al.Role of prostacyclin in the cardiovascular response to thromboxome A2.Science,2002,296:539-541.
  • 9Williams D,Kim KS,Adams-Camphell LL.Survival benefit from calcium channel blockers in elderly blacks following acute myocardial infarction.Etha DIa,2002,12:229-223.
  • 10Virdis,Agoetino,Sehifrin,et al.Vascular inflammation:a role in vascular disease in hypertension.Current Opinion in Nephrology and Hypertension,2003,12(2):181.

二级参考文献28

共引文献121

同被引文献172

引证文献11

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部